1. Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) has become a significant health concern not only in the US but also worldwide due to the global obesity epidemic. DOI:http://dx.doi.org/10.47829/JJGH.2021.7403
1. Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) has increasingly become a common cause of liver cirrhosis, hepatocellular carcinoma, and liver-related death. Currently, there are no therapeutic drugs that have proven efficacy and safety through randomized controlled clinical trial.
1. Abstract With the increasingly global epidemic of obese and metabolic syndrome, non-alcoholic steatohepatitis (NASH) has become a growing common cause of cirrhosis, hepatocellular carcinoma, and end-stage liver disease.
1. Abstract In recent years, the prevalence of liver diseases such as hepatitis B (or C) virus infection (HBV or HCV), non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have received much attention world-wide. DOI:http://dx.doi.org/10.47829/JJGH.2021.7402
1. Abstract The aim of the present article was to demonstrate the clinical case of a quite rare combination of hepatocellular carcinoma and liver alveolar echinococcosis. The literature review showed that the combination of these nosological forms of the liver damage was extremely rare. DOI:http://dx.doi.org/10.47829/JJGH.2021.7401
1. Abstract 1.1. Background: Hypervolemic hyponatremia is seen in nearly half of the patients with cirrhosis. There is a scarcity of data correlating hyponatremia with either liver/renal function markers or mortality in patients with decompensated cirrhosis. DOI:http://dx.doi.org/10.47829/JJGH.2021.7302
1. Abstract 1.1. Introduction: Plexiform Fibromyxoma (PF), also known as plexiform angiomyxoid myofibroblastic tumour (PAMT) is a rare mesenchymal myxoid tumour originating in different areas of the digestive system. Symptoms and signs are usually elusive: the most common are abdominal discomfort, dyspepsia, nausea and gastrointestinal bleeding with anemia and hematemesis. DOI:http://dx.doi.org/10.47829/JJGH.2021.7301
1. Abstract 1.1. Background and Objectives: Esophagheal cancer is one of the deadliest cancers, because in addition to its high prevalence, mortality rate is also high and puts it at the sixth place in terms of mortality. The most commonly used treatment in these patients is surgery. People with tumors in higher stages may also …
1. Abstract Caroli Disease (CD) or caroli syndrome is a rare congenital liver disease characterized by non-obstructive cystic dilatations of the intra-hepatic and rarely extra-hepatic bile ducts.
1. Abstract Bleeding from ruptured esophageal varices is a fatal complication in patients with portal hypertension. Early rebleeding occurs frequently in the first few weeks after ligation.
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.